The Anti-CS1 Elotuzumab Biosimilar (MAB-HDBS0002) is a monoclonal antibody designed for research involving CS1, a cell surface glycoprotein commonly found on multiple myeloma cells. This biosimilar antibody, similar to Elotuzumab, is highly specific and binds to CS1 with high affinity, allowing for the detection and analysis of CS1-expressing cells.CS1, also known as SLAMF7, plays a crucial role in multiple myeloma cell survival and proliferation, making it a promising target for immunotherapy. The Anti-CS1 Elotuzumab Biosimilar offers researchers a valuable tool for studying the mechanisms of action of CS1 and exploring its potential as a therapeutic target in the treatment of multiple myeloma.
With its high specificity and affinity for CS1, this biosimilar antibody is suitable for various research applications, including flow cytometry, immunohistochemistry, and functional assays. Its reliable performance and consistent results make it an essential tool for advancing our understanding of CS1 biology and developing novel treatment strategies for multiple myeloma.
Product Name:
Elotuzumab (Anti-CS1) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0002
Target:
CS1
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
BMS-901608, HuLuc63, PDL-063, PDL063
Description:
Anti-CS1 (elotuzumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.